• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

Lynthera Corporation

Monday, June 03, 2024
Company Presentation
Ophthalmology
Company Presentation Theater 3
Lynthera is a biomedical company specializing in the research and development of drug delivery and formulation technology. We have created a novel technology platform for the controlled release of ocular therapeutics. This technology has been demonstrated through our development of a drug delivery contact lens (DDCL) product for the treatment of glaucoma, dry eye, and ocular allergy.
Lynthera Corporation
Company Website: http://www.lynthera.com
Lead Product in Development: Drug-eluting contact lens for dry eye
Number Of Unlicensed Products (For Which You Are Seeking Partners): 5

Company HQ City

Lancaster

Company HQ State

Pennsylvania

Company HQ Country

United States

CEO/Top Company Official

Jeff Yang

Development Phase of Primary Product

Pre-Clinical
Primary Speaker
Jeff Yang, BA
President & CEO
Lynthera Corporation
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS